Compile Data Set for Download or QSAR
Report error Found 489 of affinity data for UniProtKB/TrEMBL: P03423
TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561471(US11390631, Example 13 | US12268694, Example 13)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM731831(Step b | US12268694, Example 272)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561472(US11390631, Example 14 | US12268694, Example 14)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561713(US11390631, Example 250 | US12268694, Example 250)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM731804(Step a | US12268694, Example 245)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561899(US11390631, Example 442 | US12268694, Example 253)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561715(US11390631, Example 252 | US12268694, Example 252)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561714(US11390631, Example 251 | US12268694, Example 251)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561760(US11390631, Example 297 | US12268694, Example 297)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561758(US11390631, Example 295 | US12268694, Example 295)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561757(US11390631, Example 294 | US12268694, Example 294)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561755(US11390631, Example 292 | US12268694, Example 292)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561511(US11390631, Example 52 | US12268694, Example 52)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561768(US11390631, Example 305 | US12268694, Example 305)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561767(US11390631, Example 304 | US12268694, Example 304)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM731862(US12268694, Example 303)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561764(US11390631, Example 301 | US12268694, Example 301)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561763(US11390631, Example 300 | Step c | US12268694, Exa...)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561762(US11390631, Example 299 | US12268694, Example 299)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561744(US11390631, Example 281 | US12268694, Example 281)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561743(US11390631, Example 280 | US12268694, Example 280)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561742(US11390631, Example 279 | US12268694, Example 279)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561741(US11390631, Example 278 | US12268694, Example 278)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561740(US11390631, Example 277 | US12268694, Example 277)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561752(US11390631, Example 289 | US12268694, Example 289)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561749(US11390631, Example 286 | US12268694, Example 286)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561748(US11390631, Example 285 | US12268694, Example 285)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM731889(Step a | US12268694, Example 330)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561792(US11390631, Example 329 | US12268694, Example 329)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561788(US11390631, Example 325 | US12268694, Example 325)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM731883(Step a | US12268694, Example 324)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561786(US11390631, Example 323 | Step b | US12268694, Exa...)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM731897(Step c | US12268694, Example 338)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561800(US11390631, Example 337 | US12268694, Example 337)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561799(US11390631, Example 336 | Step b | US12268694, Exa...)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM731894(Step a | US12268694, Example 335)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561797(US11390631, Example 334 | US12268694, Example 334)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM731873(Step a | US12268694, Example 314)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561776(US11390631, Example 313 | Step b | US12268694, Exa...)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561774(US11390631, Example 311 | Step e | US12268694, Exa...)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561514(US11390631, Example 55 | US12268694, Example 55)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561513(US11390631, Example 54 | US12268694, Example 54)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561785(US11390631, Example 322 | US12268694, Example 322)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561784(US11390631, Example 321 | US12268694, Example 321)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561781(US11390631, Example 318 | Step d | US12268694, Exa...)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM731876(Step c | US12268694, Example 317)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561824(US11390631, Example 361 | US12268694, Example 361)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM731919(US12268694, Example 360)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM731918(US12268694, Example 359)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetMajor surface glycoprotein G()
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM731917(US12268694, Example 358)
Affinity DataEC50: <400nMAssay Description:HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 cells per well in a volume of 50 μL using Growth Media (DMEM without pheno...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

Displayed 1 to 50 (of 489 total ) | Next | Last >>
Jump to: